Skip to main content
Top
Published in: Endocrine 2/2019

01-02-2019 | Original Article

ATP mediates a negative autocrine signal on stimulus-secretion coupling in mouse pancreatic β-cells

Authors: Cita Bauer, Julia Kaiser, Jelena Sikimic, Peter Krippeit-Drews, Martina Düfer, Gisela Drews

Published in: Endocrine | Issue 2/2019

Login to get access

Abstract

Purpose

The role of ATP, which is secreted by pancreatic β-cells, is still a matter of debate. It has been postulated that extracellular ATP acts as a positive auto- or paracrine signal in β-cells amplifying insulin secretion. However, there is rising evidence that extracellular ATP may also mediate a negative signal.

Methods

We evaluated whether extracellular ATP interferes with the Ca2+-mediated negative feedback mechanism that regulates oscillatory activity of β-cells.

Results

To experimentally uncover the Ca2+-induced feedback we applied a high extracellular Ca2+ concentration. Under this condition ATP (100 µM) inhibited glucose-evoked oscillations of electrical activity and hyperpolarized the membrane potential. Furthermore, ATP acutely increased the interburst phase of Ca2+ oscillations and reduced the current through L-type Ca2+ channels. Accordingly, ATP (500 µM) decreased glucose-induced insulin secretion. The ATP effect was not mimicked by AMP, ADP, or adenosine. The use of specific agonists and antagonists and mice deficient of large conductance Ca2+-dependent K+ channels revealed that P2X, but not P2Y receptors, and Ca2+-dependent K+ channels are involved in the underlying signaling cascade induced by ATP. The effectiveness of ATP to interfere with parameters of stimulus-secretion coupling is markedly reduced at low extracellular Ca2+ concentration.

Conclusion

It is suggested that extracellular ATP which is co-secreted with insulin in a pulsatile manner during glucose-stimulated exocytosis provides a negative feedback signal driving β-cell oscillations in co-operation with Ca2+ and other signals.
Appendix
Available only for authorised users
Literature
2.
go back to reference J.C. Hutton, E.J. Penn, M. Peshavaria, Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem. J. 210(2), 297–305 (1983)CrossRefPubMedPubMedCentral J.C. Hutton, E.J. Penn, M. Peshavaria, Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem. J. 210(2), 297–305 (1983)CrossRefPubMedPubMedCentral
5.
go back to reference M. Cieslak, K. Roszek, Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes. Acta Biochim. Pol. 61(4), 655–662 (2014)CrossRef M. Cieslak, K. Roszek, Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes. Acta Biochim. Pol. 61(4), 655–662 (2014)CrossRef
8.
go back to reference P. Petit, G. Bertrand, W. Schmeer, J.C. Henquin, Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic beta-cells. Br. J. Pharmacol. 98(3), 875–882 (1989)CrossRefPubMedPubMedCentral P. Petit, G. Bertrand, W. Schmeer, J.C. Henquin, Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic beta-cells. Br. J. Pharmacol. 98(3), 875–882 (1989)CrossRefPubMedPubMedCentral
9.
go back to reference C.R. Poulsen, K. Bokvist, H.L. Olsen, M. Hoy, K. Capito, P. Gilon, J. Gromada, Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells. Diabetes 48(11), 2171–2181 (1999)CrossRefPubMed C.R. Poulsen, K. Bokvist, H.L. Olsen, M. Hoy, K. Capito, P. Gilon, J. Gromada, Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells. Diabetes 48(11), 2171–2181 (1999)CrossRefPubMed
15.
go back to reference F. Blachier, W.J. Malaisse, Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochim. Biophys. Acta 970(2), 222–229 (1988)CrossRefPubMed F. Blachier, W.J. Malaisse, Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochim. Biophys. Acta 970(2), 222–229 (1988)CrossRefPubMed
17.
go back to reference P. Petit, M. Manteghetti, R. Puech, M.M. Loubatieres-Mariani, ATP and phosphate-modified adenine nucleotide analogues. Effects on insulin secretion and calcium uptake. Biochem. Pharmacol. 36(3), 377–380 (1987)CrossRefPubMed P. Petit, M. Manteghetti, R. Puech, M.M. Loubatieres-Mariani, ATP and phosphate-modified adenine nucleotide analogues. Effects on insulin secretion and calcium uptake. Biochem. Pharmacol. 36(3), 377–380 (1987)CrossRefPubMed
24.
go back to reference G. Grynkiewicz, M. Poenie, R.Y. Tsien, A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260(6), 3440–3450 (1985)PubMed G. Grynkiewicz, M. Poenie, R.Y. Tsien, A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260(6), 3440–3450 (1985)PubMed
26.
go back to reference J.C. Henquin, Glucose-induced electrical activity in beta-cells. Feedback control of ATP-sensitive K+ channels by Ca2+? [corrected]. Diabetes 39(11), 1457–1460 (1990)CrossRefPubMed J.C. Henquin, Glucose-induced electrical activity in beta-cells. Feedback control of ATP-sensitive K+ channels by Ca2+? [corrected]. Diabetes 39(11), 1457–1460 (1990)CrossRefPubMed
27.
go back to reference P. Krippeit-Drews, M. Düfer, G. Drews, Parallel oscillations of intracellular calcium activity and mitochondrial membrane potential in mouse pancreatic B-cells. Biochem. Biophys. Res. Commun. 267(1), 179–183 (2000). doi:10.1006/bbrc.1999.1921 S0006-291X(99)91921-6 [pii]CrossRefPubMed P. Krippeit-Drews, M. Düfer, G. Drews, Parallel oscillations of intracellular calcium activity and mitochondrial membrane potential in mouse pancreatic B-cells. Biochem. Biophys. Res. Commun. 267(1), 179–183 (2000). doi:10.1006/bbrc.1999.1921 S0006-291X(99)91921-6 [pii]CrossRefPubMed
28.
29.
go back to reference Maczewsky, J., Sikimic, J., Bauer, C., Krippeit-Drews, P., Wolke, C., Lendeckel, U., Barthlen, W., Drews, G. The LXR ligand T0901317 acutely inhibits insulin secretion by affecting mitochondrial metabolism. Endocrinology (2017). https://doi.org/10.1210/en.2016-1941 Maczewsky, J., Sikimic, J., Bauer, C., Krippeit-Drews, P., Wolke, C., Lendeckel, U., Barthlen, W., Drews, G. The LXR ligand T0901317 acutely inhibits insulin secretion by affecting mitochondrial metabolism. Endocrinology (2017). https://​doi.​org/​10.​1210/​en.​2016-1941
30.
go back to reference A. Salehi, S.S. Qader, E. Grapengiesser, B. Hellman, Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 54(7), 2126–2131 (2005)CrossRefPubMed A. Salehi, S.S. Qader, E. Grapengiesser, B. Hellman, Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 54(7), 2126–2131 (2005)CrossRefPubMed
31.
go back to reference M. Düfer, B. Gier, D. Wolpers, P. Krippeit-Drews, P. Ruth, G. Drews, Enhanced glucose tolerance by SK4 channel inhibition in pancreatic beta-cells. Diabetes 58, 1835–1843 (2009). doi:db08-1324 [pii] 10.2337/db08-1324CrossRefPubMedPubMedCentral M. Düfer, B. Gier, D. Wolpers, P. Krippeit-Drews, P. Ruth, G. Drews, Enhanced glucose tolerance by SK4 channel inhibition in pancreatic beta-cells. Diabetes 58, 1835–1843 (2009). doi:db08-1324 [pii] 10.2337/db08-1324CrossRefPubMedPubMedCentral
36.
go back to reference E. Gylfe, B. Hellman, External ATP mimics carbachol in initiating calcium mobilization from pancreatic beta-cells conditioned by previous exposure to glucose. Br. J. Pharmacol. 92(2), 281–289 (1987)CrossRefPubMedPubMedCentral E. Gylfe, B. Hellman, External ATP mimics carbachol in initiating calcium mobilization from pancreatic beta-cells conditioned by previous exposure to glucose. Br. J. Pharmacol. 92(2), 281–289 (1987)CrossRefPubMedPubMedCentral
37.
go back to reference N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J.D. Veldhuis, O. Schmitz, Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51(Suppl 1), S245–254 (2002)CrossRefPubMed N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J.D. Veldhuis, O. Schmitz, Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51(Suppl 1), S245–254 (2002)CrossRefPubMed
38.
go back to reference A. Hazama, S. Hayashi, Y. Okada, Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflug. Arch. 437(1), 31–35 (1998)CrossRef A. Hazama, S. Hayashi, Y. Okada, Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflug. Arch. 437(1), 31–35 (1998)CrossRef
39.
go back to reference K. Nakazawa, K. Fujimori, A. Takanaka, K. Inoue, An ATP-activated conductance in pheochromocytoma cells and its suppression by extracellular calcium. J. Physiol. 428, 257–272 (1990)CrossRefPubMedPubMedCentral K. Nakazawa, K. Fujimori, A. Takanaka, K. Inoue, An ATP-activated conductance in pheochromocytoma cells and its suppression by extracellular calcium. J. Physiol. 428, 257–272 (1990)CrossRefPubMedPubMedCentral
40.
go back to reference J.F. Rolland, J.C. Henquin, P. Gilon, Feedback control of the ATP-sensitive K+ current by cytosolic Ca2+ contributes to oscillations of the membrane potential in pancreatic beta-cells. Diabetes 51(2), 376–384 (2002)CrossRefPubMed J.F. Rolland, J.C. Henquin, P. Gilon, Feedback control of the ATP-sensitive K+ current by cytosolic Ca2+ contributes to oscillations of the membrane potential in pancreatic beta-cells. Diabetes 51(2), 376–384 (2002)CrossRefPubMed
41.
go back to reference Q. Gong, M. Kakei, N. Koriyama, M. Nakazaki, S. Morimitsu, K. Yaekura, C. Tei, P2Y-purinoceptor mediated inhibition of L-type Ca2+ channels in rat pancreatic beta-cells. Cell Struct. Funct. 25(5), 279–289 (2000)CrossRefPubMed Q. Gong, M. Kakei, N. Koriyama, M. Nakazaki, S. Morimitsu, K. Yaekura, C. Tei, P2Y-purinoceptor mediated inhibition of L-type Ca2+ channels in rat pancreatic beta-cells. Cell Struct. Funct. 25(5), 279–289 (2000)CrossRefPubMed
42.
go back to reference M.C. Jacques-Silva, M. Correa-Medina, O. Cabrera, R. Rodriguez-Diaz, N. Makeeva, A. Fachado, J. Diez, D.M. Berman, N.S. Kenyon, C. Ricordi, A. Pileggi, R.D. Molano, P.O. Berggren, A. Caicedo, ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc. Natl. Acad. Sci. USA 107(14), 6465–6470 (2010). doi:0908935107 [pii] 10.1073/pnas.0908935107CrossRefPubMed M.C. Jacques-Silva, M. Correa-Medina, O. Cabrera, R. Rodriguez-Diaz, N. Makeeva, A. Fachado, J. Diez, D.M. Berman, N.S. Kenyon, C. Ricordi, A. Pileggi, R.D. Molano, P.O. Berggren, A. Caicedo, ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc. Natl. Acad. Sci. USA 107(14), 6465–6470 (2010). doi:0908935107 [pii] 10.1073/pnas.0908935107CrossRefPubMed
43.
go back to reference J. Fernandez-Alvarez, D. Hillaire-Buys, M.M. Loubatieres-Mariani, R. Gomis, P. Petit, P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 22(1), 69–71 (2001)CrossRefPubMed J. Fernandez-Alvarez, D. Hillaire-Buys, M.M. Loubatieres-Mariani, R. Gomis, P. Petit, P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 22(1), 69–71 (2001)CrossRefPubMed
Metadata
Title
ATP mediates a negative autocrine signal on stimulus-secretion coupling in mouse pancreatic β-cells
Authors
Cita Bauer
Julia Kaiser
Jelena Sikimic
Peter Krippeit-Drews
Martina Düfer
Gisela Drews
Publication date
01-02-2019
Publisher
Springer US
Published in
Endocrine / Issue 2/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1731-0

Other articles of this Issue 2/2019

Endocrine 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine